Aberrant DNA Methylation of ABC Transporters in Cancer

被引:25
|
作者
Zappe, Katja [1 ]
Cichna-Markl, Margit [1 ]
机构
[1] Univ Vienna, Fac Chem, Dept Analyt Chem, A-1090 Vienna, Austria
关键词
ABC transporter; DNA methylation; cancer; multidrug resistance; cancer therapy; ATP-BINDING CASSETTE; SINGLE NUCLEOTIDE POLYMORPHISMS; OVERCOME MULTIDRUG-RESISTANCE; CPG ISLAND HYPERMETHYLATION; MDR1 UPSTREAM PROMOTER; HUMAN PROSTATE-CANCER; P-GLYCOPROTEIN; DRUG-RESISTANCE; MOLECULAR-MECHANISMS; GENOMIC ORGANIZATION;
D O I
10.3390/cells9102281
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
ATP-binding cassette (ABC) transporters play a crucial role in multidrug resistance (MDR) of cancers. They function as efflux pumps, resulting in limited effectiveness or even failure of therapy. Increasing evidence suggests that ABC transporters are also involved in tumor initiation, progression, and metastasis. Tumors frequently show multiple genetic and epigenetic abnormalities, including changes in histone modification and DNA methylation. Alterations in the DNA methylation status of ABC transporters have been reported for a variety of cancer types. In this review, we outline the current knowledge of DNA methylation of ABC transporters in cancer. We give a brief introduction to structure, function, and gene regulation of ABC transporters that have already been investigated for their DNA methylation status in cancer. After giving an overview of the applied methodologies and the CpGs analyzed, we summarize and discuss the findings on aberrant DNA methylation of ABC transporters by cancer types. We conclude our review with the discussion of the potential to target aberrant DNA methylation of ABC transporters for cancer therapy.
引用
收藏
页数:35
相关论文
共 50 条
  • [1] Aberrant DNA Methylation and Prostate Cancer
    Majumdar, Sunipa
    Buckles, Eric
    Estrada, John
    Koochekpour, Shahriar
    [J]. CURRENT GENOMICS, 2011, 12 (07) : 486 - 505
  • [2] MethCancerDB – aberrant DNA methylation in human cancer
    M Lauss
    I Visne
    A Weinhaeusel
    K Vierlinger
    C Noehammer
    A Kriegner
    [J]. British Journal of Cancer, 2008, 98 : 816 - 817
  • [3] MethCancerDB - aberrant DNA methylation in human cancer
    Lauss, M.
    Visne, I.
    Weinhaeusel, A.
    Vierlinger, K.
    Noehammer, C.
    Kriegner, A.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (04) : 816 - 817
  • [4] Understanding the origins of aberrant DNA methylation in cancer
    Stancheva, I.
    Gordon, K.
    Sundaram, A.
    [J]. EJC SUPPLEMENTS, 2010, 8 (05): : 85 - 85
  • [5] Aberrant DNA Methylation, Expression, and Occurrence of Transcript Variants of the ABC Transporter ABCA7 in Breast Cancer
    Zappe, Katja
    Kopic, Antonio
    Scheichel, Alexandra
    Schier, Ann-Katrin
    Schmidt, Lukas Emanuel
    Borutzki, Yasmin
    Miedl, Heidi
    Schreiber, Martin
    Mendrina, Theresa
    Pirker, Christine
    Pfeiler, Georg
    Hacker, Stefan
    Haslik, Werner
    Pils, Dietmar
    Bileck, Andrea
    Gerner, Christopher
    Meier-Menches, Samuel
    Heffeter, Petra
    Cichna-Markl, Margit
    [J]. CELLS, 2023, 12 (11)
  • [6] Epimutations, inheritance and causes of aberrant DNA methylation in cancer
    Mossman D.
    Scott R.J.
    [J]. Hereditary Cancer in Clinical Practice, 4 (2) : 75 - 80
  • [7] Aberrant DNA methylation as a cancer-inducing mechanism
    Esteller, M
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 : 629 - 656
  • [8] Compendium of aberrant DNA methylation and histone modifications in cancer
    Hattori, Naoko
    Ushijima, Toshikazu
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 455 (1-2) : 3 - 9
  • [9] Aberrant DNA Methylation in Keratoacanthoma
    Nobeyama, Yoshimasa
    Nakagawa, Hidemi
    [J]. PLoS One, 2016, 11 (10):
  • [10] DNA Methylation Aberrant in Atherosclerosis
    Dai, Yao
    Chen, Danian
    Xu, Tingting
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13